Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ligand Pharmaceuticals - 33 Year Stock Price History | LGND

Historical daily share price chart and data for Ligand Pharmaceuticals since 1992 adjusted for splits and dividends. The latest closing stock price for Ligand Pharmaceuticals as of January 17, 2025 is 111.89.
  • The all-time high Ligand Pharmaceuticals stock closing price was 274.49 on September 28, 2018.
  • The Ligand Pharmaceuticals 52-week high stock price is 129.90, which is 16.1% above the current share price.
  • The Ligand Pharmaceuticals 52-week low stock price is 67.72, which is 39.5% below the current share price.
  • The average Ligand Pharmaceuticals stock price for the last 52 weeks is 93.90.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ligand Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 109.2482 108.4200 111.8900 105.8600 111.8900 4.42%
2024 92.0149 72.3100 129.9000 68.5300 107.1500 50.03%
2023 67.6952 66.0300 79.3300 49.5700 71.4200 6.92%
2022 94.5155 151.5600 151.5600 62.0000 66.8000 -56.75%
2021 139.1143 101.0700 215.8300 99.5200 154.4600 55.31%
2020 98.3573 104.7400 126.7200 63.3700 99.4500 -4.64%
2019 111.6805 137.0000 142.4700 86.2500 104.2900 -23.15%
2018 187.6862 138.6300 274.4900 128.3600 135.7000 -0.90%
2017 120.9272 102.5000 147.0400 100.3800 136.9300 34.76%
2016 108.9749 102.4700 138.5300 85.7900 101.6100 -6.28%
2015 86.5684 53.7300 111.8500 51.5400 108.4200 103.76%
2014 59.1922 51.5200 79.5800 42.3600 53.2100 1.16%
2013 37.1462 20.7200 57.9500 19.1602 52.6000 153.62%
2012 15.9545 11.9100 21.5300 11.4900 20.7400 74.73%
2011 11.4795 8.9900 15.9500 8.6500 11.8700 33.07%
2010 9.8156 13.0200 13.0200 8.2700 8.9200 -31.49%
2009 15.3079 16.2000 18.9000 9.9600 13.0200 -20.80%
2008 19.3233 29.1600 29.1600 7.6200 16.4400 -43.27%
2007 40.0625 49.1926 58.5712 23.4000 28.9800 -41.30%
2006 49.4716 51.8529 62.2356 35.8461 49.3730 -1.79%
2005 37.0503 50.5002 52.5292 21.4175 50.2748 -4.21%
2004 64.4892 67.3186 108.3049 35.4403 52.4841 -20.76%
2003 48.4792 24.6639 72.6842 16.8184 66.2364 173.56%
2002 51.9901 76.8775 90.1338 22.1389 24.2130 -70.00%
2001 54.3123 61.9980 85.6700 35.3952 80.7101 27.86%
2000 63.8520 62.5842 114.7076 44.3680 63.1252 8.70%
1999 44.1596 50.4551 62.8547 29.5787 58.0752 10.75%
1998 53.9537 57.4891 72.7293 25.9264 52.4390 -9.71%
1997 60.3340 69.2574 82.5588 41.1667 58.0752 -13.44%
1996 59.4135 46.8029 85.6700 46.2167 67.0931 38.42%
1995 35.4426 36.0716 49.5984 24.7992 48.4712 30.30%
1994 53.3798 54.1074 64.2525 28.1809 37.1988 -29.79%
1993 46.0966 55.2346 55.2346 39.4533 52.9801 11.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.114B $0.131B
Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated chemically modified cyclodextrin that is designed to improve safety and solubility, stability, and bioavailability or lessen the volatility, irritation, smell or taste of drugs. Ligand has merged with CyDex. By this, it added an antibody-generating platform, OmniAb, to the company's portfolio. Its other technology platforms include antigen discovery platform & protein expression platform. All these technologies have created a strong platform for Ligand to seek new licenses and partnerships. Ligand has partnership agreements with leading healthcare companies like Novartis, Amgen, Merck, Pfizer, Celgene, Gilead & Lilly, etc. The company continues to buy smaller companies to increase its technology platforms.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.268B 14.16
Gilead Sciences (GILD) United States $114.457B 20.73
Bristol Myers Squibb (BMY) United States $114.166B 48.11
Vertex Pharmaceuticals (VRTX) United States $108.677B 0.00
CSL (CSLLY) Australia $83.439B 0.00
Regeneron Pharmaceuticals (REGN) United States $74.899B 17.05
GSK (GSK) United Kingdom $69.286B 8.02
Argenex SE (ARGX) Netherlands $38.667B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.764B 0.00
BioNTech SE (BNTX) Germany $26.834B 0.00
Illumina (ILMN) United States $21.676B 79.00
BeiGene (ONC) Cayman Islands $20.529B 0.00
Biogen (BIIB) United States $20.481B 8.80
Incyte (INCY) United States $13.857B 0.00
Genmab (GMAB) Denmark $13.765B 20.19
Genmab (GNMSF) Denmark $13.706B 16.44
Intra-Cellular Therapies (ITCI) United States $13.379B 0.00
Moderna (MRNA) United States $13.107B 0.00
Insmed (INSM) United States $12.972B 0.00
Bio-Techne Corp (TECH) United States $12.049B 46.52
BioMarin Pharmaceutical (BMRN) United States $11.727B 27.23
Sarepta Therapeutics (SRPT) United States $11.271B 101.72
Vaxcyte (PCVX) United States $10.632B 0.00
QIAGEN (QGEN) Netherlands $10.497B 21.60
Exelixis (EXEL) United States $10.338B 23.51
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Exact Sciences (EXAS) United States $9.576B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.547B 32.44
Repligen (RGEN) United States $8.993B 117.16
Roivant Sciences (ROIV) United Kingdom $8.117B 0.00
Ascendis Pharma (ASND) Denmark $7.776B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.326B 7.17
Zealand Pharma (ZLDPF) Denmark $7.065B 0.00
Blueprint Medicines (BPMC) United States $6.991B 0.00
Halozyme Therapeutics (HALO) United States $6.972B 15.75
Revolution Medicines (RVMD) United States $6.778B 0.00
Legend Biotech (LEGN) United States $5.965B 0.00
Telix Pharmaceuticals (TLX) Australia $5.617B 0.00
Cytokinetics (CYTK) United States $5.398B 0.00
Nuvalent (NUVL) United States $5.389B 0.00
Alkermes (ALKS) Ireland $4.768B 16.02
TG Therapeutics (TGTX) United States $4.600B 0.00
Guardant Health (GH) United States $4.530B 0.00
Axsome Therapeutics (AXSM) United States $4.455B 0.00
Krystal Biotech (KRYS) United States $4.268B 70.66
Verona Pharma American Depositary Share (VRNA) United Kingdom $4.215B 0.00
Scholar Rock Holding (SRRK) United States $4.038B 0.00
Alvotech (ALVO) Luxembourg $4.001B 0.00
Biohaven (BHVN) United States $3.801B 0.00
ADMA Biologics Inc (ADMA) United States $3.787B 40.05
Apellis Pharmaceuticals (APLS) United States $3.724B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.694B 0.00
Viking Therapeutics (VKTX) United States $3.638B 0.00
Arcellx (ACLX) United States $3.595B 0.00
Immunovant (IMVT) United States $3.502B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.459B 0.00
Avidity Biosciences (RNA) United States $3.450B 0.00
PTC Therapeutics (PTCT) United States $3.381B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.352B 0.00
Denali Therapeutics (DNLI) United States $3.156B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.937B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.924B 22.53
Vericel (VCEL) United States $2.916B 984.50
Zai Lab (ZLAB) China $2.851B 0.00
NovoCure (NVCR) Jersey $2.832B 0.00
Twist Bioscience (TWST) United States $2.823B 0.00
Amicus Therapeutics (FOLD) United States $2.812B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.800B 0.00
Merus (MRUS) Netherlands $2.701B 0.00
Kymera Therapeutics (KYMR) United States $2.630B 0.00
SpringWorks Therapeutics (SWTX) United States $2.576B 0.00
Edgewise Therapeutics (EWTX) United States $2.487B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.475B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.434B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.254B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.227B 18.51
CG Oncology (CGON) United States $2.211B 0.00
Protagonist Therapeutics (PTGX) United States $2.194B 13.84
Janux Therapeutics (JANX) United States $2.137B 0.00
Bavarian Nordic (BVNRY) Denmark $2.130B 13.05
Vera Therapeutics (VERA) United States $2.113B 0.00
ImmunityBio (IBRX) United States $2.049B 0.00
Mesoblast (MESO) Australia $1.984B 0.00
Beam Therapeutics (BEAM) United States $1.941B 0.00
IDEAYA Biosciences (IDYA) United States $1.917B 0.00
Certara (CERT) United States $1.877B 53.00
Agios Pharmaceuticals (AGIO) United States $1.849B 0.00
NeoGenomics (NEO) United States $1.824B 0.00
Iovance Biotherapeutics (IOVA) United States $1.801B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.778B 0.00
Akero Therapeutics (AKRO) United States $1.755B 0.00
Geron (GERN) United States $1.747B 0.00
Belite Bio (BLTE) United States $1.736B 0.00
Disc Medicine (IRON) United States $1.733B 0.00
WAVE Life Sciences (WVE) Singapore $1.676B 0.00
Apogee Therapeutics (APGE) United States $1.669B 0.00
MannKind (MNKD) United States $1.657B 42.93
Dynavax Technologies (DVAX) United States $1.637B 95.77
Fortrea Holdings (FTRE) United States $1.587B 50.54
Celldex Therapeutics (CLDX) United States $1.578B 0.00
Galapagos (GLPG) Belgium $1.566B 0.00
Structure Therapeutics (GPCR) United States $1.549B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.484B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.452B 0.00
Viridian Therapeutics (VRDN) United States $1.436B 0.00
Travere Therapeutics (TVTX) United States $1.434B 0.00
Vir Biotechnology (VIR) United States $1.392B 0.00
Nurix Therapeutics (NRIX) United States $1.356B 0.00
Novavax (NVAX) United States $1.346B 0.00
MiMedx (MDXG) United States $1.340B 35.08
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.339B 0.00
Praxis Precision Medicines (PRAX) United States $1.315B 0.00
Arcus Biosciences (RCUS) United States $1.284B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.265B 0.00
Arvinas (ARVN) United States $1.240B 0.00
ANI Pharmaceuticals (ANIP) United States $1.229B 16.75
Myriad Genetics (MYGN) United States $1.128B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.116B 0.00
Liquidia Technologies (LQDA) United States $1.091B 0.00
Spyre Therapeutics (SYRE) United States $1.061B 0.00
Pacira BioSciences (PCRX) United States $1.032B 9.72
Gyre Therapeutics (GYRE) United States $1.024B 0.00
Adaptive Biotechnologies (ADPT) United States $1.005B 0.00
Intellia Therapeutics (NTLA) United States $0.968B 0.00
Pharvaris (PHVS) Netherlands $0.960B 0.00
Zymeworks (ZYME) United States $0.956B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.940B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.921B 0.00
Oculis Holding AG (OCS) Switzerland $0.921B 0.00
CureVac (CVAC) Germany $0.918B 7.45
Cogent Biosciences (COGT) United States $0.887B 0.00
AbCellera Biologics (ABCL) Canada $0.877B 0.00
Nuvation Bio (NUVB) United States $0.845B 0.00
ArriVent BioPharma (AVBP) United States $0.823B 0.00
Tyra Biosciences (TYRA) United States $0.819B 0.00
Avid Bioservices (CDMO) United States $0.793B 0.00
Anavex Life Sciences (AVXL) United States $0.781B 0.00
Septerna (SEPN) United States $0.750B 0.00
Prothena (PRTA) Ireland $0.741B 0.00
CorMedix Inc (CRMD) United States $0.738B 0.00
Sana Biotechnology (SANA) United States $0.706B 0.00
Cytek Biosciences (CTKB) United States $0.703B 0.00
Castle Biosciences (CSTL) United States $0.699B 124.70
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.696B 0.00
Replimune (REPL) United States $0.694B 0.00
UniQure (QURE) Netherlands $0.685B 0.00
Pliant Therapeutics (PLRX) United States $0.682B 0.00
Pharming Group (PHAR) Netherlands $0.679B 0.00
Oric Pharmaceuticals (ORIC) United States $0.676B 0.00
89BIO (ETNB) United States $0.670B 0.00
Bicara Therapeutics (BCAX) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Immatics (IMTX) Germany $0.639B 0.00
Immunome (IMNM) United States $0.624B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.623B 0.00
LENZ Therapeutics (LENZ) United States $0.619B 0.00
Arbutus Biopharma (ABUS) United States $0.606B 0.00
Tectonic Therapeutic (TECX) United States $0.603B 0.00
Cullinan Therapeutics (CGEM) United States $0.597B 0.00
Dianthus Therapeutics (DNTH) United States $0.592B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.591B 0.00
Upstream Bio (UPB) United States $0.590B 0.00
GRAIL (GRAL) United States $0.585B 0.00
CARGO Therapeutics (CRGX) United States $0.570B 0.00
Kura Oncology (KURA) United States $0.565B 0.00
Humacyte (HUMA) United States $0.555B 0.00
Emergent Biosolutions (EBS) United States $0.535B 0.00
Opthea (OPT) Australia $0.531B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.525B 0.00
Erasca (ERAS) United States $0.523B 0.00
MaxCyte (MXCT) United States $0.522B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.511B 0.00
Stoke Therapeutics (STOK) United States $0.496B 0.00
Cartesian Therapeutics (RNAC) United States $0.490B 0.00
MeiraGTx Holdings (MGTX) United States $0.489B 0.00
AnaptysBio (ANAB) United States $0.482B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.476B 0.00
Entrada Therapeutics (TRDA) United States $0.475B 7.98
Rapport Therapeutics (RAPP) United States $0.464B 0.00
GH Research (GHRS) Ireland $0.462B 0.00
Mineralys Therapeutics (MLYS) United States $0.460B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.455B 0.00
ChromaDex (CDXC) United States $0.454B 594.00
Annexon (ANNX) United States $0.448B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.444B 0.00
Keros Therapeutics (KROS) United States $0.440B 0.00
Sage Therapeutics (SAGE) United States $0.433B 0.00
Alpha Teknova (TKNO) United States $0.430B 0.00
Astria Therapeutics (ATXS) United States $0.423B 0.00
PureTech Health (PRTC) United States $0.419B 0.00
Kamada (KMDA) Israel $0.412B 25.57
Codexis (CDXS) United States $0.407B 0.00
Celcuity (CELC) United States $0.406B 0.00
Abivax SA (ABVX) France $0.390B 0.00
Aura Biosciences (AURA) United States $0.388B 0.00
Revance Therapeutics (RVNC) United States $0.384B 0.00
Allogene Therapeutics (ALLO) United States $0.382B 0.00
Prime Medicine (PRME) United States $0.379B 0.00
Kodiak Sciences (KOD) United States $0.377B 0.00
Terns Pharmaceuticals (TERN) United States $0.376B 0.00
Eton Pharmaceuticals (ETON) United States $0.375B 0.00
Northwest Biotherapeutics (NWBO) United States $0.374B 0.00
REGENXBIO (RGNX) United States $0.365B 0.00
Alumis (ALMS) United States $0.362B 0.00
Compass Therapeutics (CMPX) United States $0.358B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.347B 0.00
Absci (ABSI) United States $0.333B 0.00
Neumora Therapeutics (NMRA) United States $0.331B 0.00
MBX Biosciences (MBX) United States $0.331B 0.00
Zenas BioPharma (ZBIO) United States $0.328B 0.00
Precigen (PGEN) United States $0.325B 0.00
Olema Pharmaceuticals (OLMA) United States $0.324B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.322B 0.00
Contineum Therapeutics (CTNM) United States $0.321B 0.00
Chimerix (CMRX) United States $0.319B 0.00
EnGene Holdings (ENGN) Canada $0.316B 0.00
XOMA Royalty (XOMA) United States $0.315B 0.00
Tango Therapeutics (TNGX) United States $0.306B 0.00
ATyr Pharma (ATYR) United States $0.303B 0.00
ITeos Therapeutics (ITOS) United States $0.292B 0.00
Trevi Therapeutics (TRVI) United States $0.289B 0.00
Design Therapeutics (DSGN) United States $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.285B 0.00
Rezolute (RZLT) United States $0.282B 0.00
Prima BioMed (IMMP) Australia $0.281B 0.00
C4 Therapeutics (CCCC) United States $0.278B 0.00
Voyager Therapeutics (VYGR) United States $0.277B 7.14
Y-mAbs Therapeutics (YMAB) United States $0.276B 0.00
AC Immune (ACIU) Switzerland $0.265B 0.00
BioStem Technologies (BSEM) $0.265B 23.38
Third Harmonic Bio (THRD) United States $0.261B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.254B 0.00
Neurogene (NGNE) United States $0.247B 0.00
DiaMedica Therapeutics (DMAC) United States $0.244B 0.00
Nautilus Biotechnology (NAUT) United States $0.242B 0.00
Urogen Pharma (URGN) United States $0.241B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.240B 0.00
Lifecore Biomedical (LFCR) United States $0.240B 0.00
Foghorn Therapeutics (FHTX) United States $0.240B 0.00
Benitec Biopharma (BNTC) United States $0.239B 0.00
Verastem (VSTM) United States $0.237B 0.00
Anika Therapeutics (ANIK) United States $0.235B 0.00
Amarin (AMRN) Ireland $0.229B 0.00
Sangamo Therapeutics (SGMO) United States $0.227B 0.00
Abeona Therapeutics (ABEO) United States $0.227B 0.00
Molecular Partners AG (MOLN) Switzerland $0.224B 0.00
Semper Paratus Acquisition (TVGN) United States $0.224B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.223B 0.00
Gossamer Bio (GOSS) United States $0.218B 0.00
Candel Therapeutics (CADL) United States $0.216B 0.00
Fulcrum Therapeutics (FULC) United States $0.214B 0.00
Ocugen (OCGN) United States $0.207B 0.00
TuHURA Biosciences (HURA) United States $0.203B 0.00
Compugen (CGEN) Israel $0.201B 112.50
Orchestra BioMed Holdings (OBIO) United States $0.201B 0.00
ACELYRIN, INC (SLRN) United States $0.200B 0.00
Inhibrx Biosciences (INBX) United States $0.195B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.194B 0.00
BioAge Labs (BIOA) United States $0.184B 0.00
Adocia (ADOCY) France $0.183B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.177B 0.00
Cardiff Oncology (CRDF) United States $0.176B 0.00
Nkarta (NKTX) United States $0.174B 0.00
Monopar Therapeutics (MNPR) United States $0.174B 0.00
GENFIT S.A (GNFT) France $0.173B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.170B 0.00
Greenwich LifeSciences (GLSI) United States $0.169B 0.00
Actuate Therapeutics (ACTU) United States $0.168B 0.00
Alector (ALEC) United States $0.167B 0.00
Sutro Biopharma (STRO) United States $0.166B 0.00
ScPharmaceuticals (SCPH) United States $0.164B 0.00
Bright Minds Biosciences (DRUG) United States $0.163B 0.00
Coherus BioSciences (CHRS) United States $0.160B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.160B 0.00
Artiva Biotherapeutics (ARTV) United States $0.159B 0.00
Checkpoint Therapeutics (CKPT) United States $0.155B 0.00
Cidara Therapeutics (CDTX) United States $0.153B 0.00
Adherex Technologies (FENC) United States $0.153B 0.00
InflaRx (IFRX) Germany $0.150B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.148B 0.00
Puma Biotechnology (PBYI) United States $0.146B 6.19
Fate Therapeutics (FATE) United States $0.145B 0.00
Biomea Fusion (BMEA) United States $0.144B 0.00
Kyverna Therapeutics (KYTX) United States $0.144B 0.00
INmune Bio (INMB) United States $0.143B 0.00
Ventyx Biosciences (VTYX) United States $0.143B 0.00
Innate Pharma S.A (IPHA) France $0.142B 0.00
Akoya Biosciences (AKYA) United States $0.140B 0.00
Caribou Biosciences (CRBU) United States $0.139B 0.00
Instil Bio (TIL) United States $0.137B 0.00
Seer (SEER) United States $0.135B 0.00
Sagimet Biosciences (SGMT) United States $0.135B 0.00
2seventy Bio (TSVT) United States $0.135B 0.00
Cabaletta Bio (CABA) United States $0.134B 0.00
Climb Bio (CLYM) United States $0.131B 0.00
Seres Therapeutics (MCRB) United States $0.131B 0.00
Solid Biosciences (SLDB) United States $0.131B 0.00
TScan Therapeutics (TCRX) United States $0.128B 0.00
Alto Neuroscience (ANRO) United States $0.125B 0.00
Black Diamond Therapeutics (BDTX) United States $0.124B 0.00
Aligos Therapeutics (ALGS) United States $0.123B 0.00
XBiotech (XBIT) United States $0.116B 0.00
Zura Bio (ZURA) United States $0.116B 0.00
Inventiva S.A (IVA) France $0.113B 0.00
Renovaro (RENB) United States $0.112B 0.00
Tenaya Therapeutics (TNYA) United States $0.111B 0.00
Elutia (ELUT) United States $0.111B 0.00
Nuvectis Pharma (NVCT) United States $0.106B 0.00
TELA Bio (TELA) United States $0.106B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.106B 0.00
IGM Biosciences (IGMS) United States $0.105B 0.00
Editas Medicine (EDIT) United States $0.101B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.098B 0.00
BioHarvest Sciences (BHST) Canada $0.096B 0.00
Alpha Cognition (ACOG) Canada $0.095B 0.00
HilleVax (HLVX) United States $0.095B 0.00
23andMe Holding (ME) United States $0.094B 0.00
CAMP4 Therapeutics (CAMP) United States $0.093B 0.00
DBV Technologies S.A (DBVT) France $0.092B 0.00
ALX Oncology Holdings (ALXO) United States $0.092B 0.00
Vor Biopharma (VOR) $0.091B 0.00
Citius Oncology (CTOR) United States $0.091B 0.00
Adverum Biotechnologies (ADVM) United States $0.090B 0.00
Coya Therapeutics (COYA) United States $0.090B 0.00
MediciNova (MNOV) United States $0.090B 0.00
Inozyme Pharma (INZY) United States $0.087B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.087B 0.00
I-Mab (IMAB) China $0.087B 0.00
X4 Pharmaceuticals (XFOR) United States $0.087B 0.00
Scilex Holding (SCLX) United States $0.086B 0.00
Immunic (IMUX) United States $0.086B 0.00
Genelux (GNLX) United States $0.085B 0.00
Entera Bio (ENTX) Israel $0.084B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Jasper Therapeutics (JSPR) United States $0.083B 0.00
Cellectis S.A (CLLS) France $0.082B 0.00
Agenus (AGEN) United States $0.082B 0.00
Adagene (ADAG) China $0.081B 0.00
VistaGen Therapeutics (VTGN) United States $0.081B 0.00
Bluebird Bio (BLUE) United States $0.081B 0.00
Skye Bioscience (SKYE) United States $0.081B 0.00
Theratechnologies (THTX) Canada $0.079B 0.00
Vigil Neuroscience (VIGL) United States $0.079B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Allakos (ALLK) United States $0.076B 0.00
Mersana Therapeutics (MRSN) United States $0.076B 0.00
Applied Therapeutics (APLT) United States $0.076B 0.00
Adlai Nortye (ANL) Cayman Islands $0.076B 0.00
Rani Therapeutics Holdings (RANI) United States $0.075B 0.00
PepGen (PEPG) United States $0.075B 0.00
Adicet Bio (ACET) United States $0.075B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Aerovate Therapeutics (AVTE) United States $0.075B 0.00
Aadi Bioscience (AADI) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
Ikena Oncology (IKNA) United States $0.072B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Annovis Bio (ANVS) United States $0.069B 0.00
BGM Group (BGM) China $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
Elicio Therapeutics (ELTX) United States $0.067B 0.00
BeyondSpring (BYSI) United States $0.067B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
Abpro Holdings (ABP) United States $0.067B 0.00
Invizyne Technologies (IZTC) United States $0.066B 0.00
CytomX Therapeutics (CTMX) United States $0.066B 4.94
Generation Bio (GBIO) United States $0.063B 0.00
Oncolytics Biotech (ONCY) Canada $0.063B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
Immuneering (IMRX) United States $0.063B 0.00
FibroBiologics (FBLG) United States $0.062B 0.00
Kronos Bio (KRON) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.059B 0.00
Connect Biopharma Holdings (CNTB) United States $0.058B 0.00
Boundless Bio (BOLD) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.056B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
IO Biotech (IOBT) Denmark $0.055B 0.00
Repare Therapeutics (RPTX) Canada $0.054B 0.00
Inovio Pharmaceuticals (INO) United States $0.054B 0.00
PDS Biotechnology (PDSB) United States $0.054B 0.00
Earth Science Tech (ETST) United States $0.054B 0.00
Shattuck Labs (STTK) United States $0.053B 0.00
Ovid Therapeutics (OVID) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.052B 0.00
Fortress Biotech (FBIO) United States $0.052B 0.00
Celularity (CELU) United States $0.051B 0.00
Xilio Therapeutics (XLO) United States $0.050B 0.00
Spero Therapeutics (SPRO) United States $0.050B 13.00
Invivyd (IVVD) United States $0.049B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.047B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.045B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Aileron Therapeutics (RNTX) United States $0.043B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
Elevation Oncology (ELEV) United States $0.042B 0.00
Rapt Therapeutics (RAPT) United States $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.042B 0.00
Intensity Therapeutics (INTS) United States $0.042B 0.00
CalciMedica (CALC) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.041B 0.00
Clene (CLNN) United States $0.040B 0.00
Q32 Bio (QTTB) United States $0.040B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Precision BioSciences (DTIL) United States $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
Atara Biotherapeutics (ATRA) United States $0.038B 0.00
Grace Therapeutics (GRCE) Canada $0.037B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Rallybio (RLYB) United States $0.036B 0.00
RenovoRx (RNXT) United States $0.036B 0.00
Opus Genetics (IRD) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
MiNK Therapeutics (INKT) United States $0.035B 0.00
Enzo Biochem (ENZ) United States $0.034B 0.00
KALA BIO (KALA) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
Medicus Pharma (MDCX) Canada $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.031B 0.00
Cadrenal Therapeutics (CVKD) United States $0.031B 0.00
Chemomab Therapeutics (CMMB) Israel $0.031B 0.00
Omega Therapeutics (OMGA) United States $0.030B 0.00
Beyond Air (XAIR) United States $0.030B 0.00
UNITY Biotechnology (UBX) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Cognition Therapeutics (CGTX) United States $0.028B 0.00
Curis (CRIS) United States $0.028B 0.00
Exicure (XCUR) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
LakeShore Biopharma (LSB) China $0.025B 0.00
Longeveron (LGVN) United States $0.025B 0.00
Prana Biotechnology (ATHE) Australia $0.025B 0.00
Pluri (PLUR) Israel $0.024B 0.00
BioAtla (BCAB) United States $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
Cyclo Therapeutics (CYTH) United States $0.023B 0.00
Equillium (EQ) United States $0.023B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.022B 0.00
NextCure (NXTC) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.022B 0.00
IN8bio (INAB) United States $0.021B 0.00
Senti Biosciences (SNTI) United States $0.021B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.021B 0.00
Cara Therapeutics (CARA) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.021B 0.00
Aprea Therapeutics (APRE) United States $0.021B 0.00
Gelteq (GELS) Australia $0.021B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
OnKure Therapeutics (OKUR) United States $0.019B 0.00
Ocean Biomedical (OCEA) United States $0.019B 0.00
Affimed (AFMD) Germany $0.019B 0.00
Palvella Therapeutics (PVLA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
BioXcel Therapeutics (BTAI) United States $0.017B 0.00
MetaVia (MTVA) United States $0.017B 0.00
BRIACELL THERAP (BCTX) Canada $0.017B 0.00
NKGen Biotech (NKGN) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Spruce Biosciences (SPRB) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
CervoMed (CRVO) United States $0.013B 0.00
Aptose Biosciences (APTO) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Carmell (CTCX) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
BioAffinity Technologies (BIAF) United States $0.011B 0.00
Apollomics (APLM) United States $0.010B 0.00
Hoth Therapeutics (HOTH) United States $0.010B 0.00
Turnstone Biologics (TSBX) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Mainz Biomed (MYNZ) Germany $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
Silo Pharma (SILO) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.005B 0.00
Vincerx Pharma (VINC) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Evaxion Biotech (EVAX) Denmark $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NAYA Biosciences (NAYA) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00